Curetis USA is focused on delivering fast, reliable and cost-effective molecular solutions to aid in diagnosing severe infectious diseases. Curetis’ Unyvero is the only FDA approved system to provide U.S. clinicians with rapid and critical information for the early syndromic detection of severe pneumonia bacteria and their associated resistance markers in under 5 hours from sample to answer.